Speaker: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Anant Madabhushi, PhD (he/him/his) – Emory University

Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Co-Chair: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

Speaker: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland

Speaker: Madhav V. Dhodapkar, MD, (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA

Speaker: Vincent Rajkumar, MD – Mayo Clinic

Speaker: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

Panelist: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy

Panelist: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

Panelist: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland

Panelist: Madhav V. Dhodapkar, MD, (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA

Panelist: Vincent Rajkumar, MD – Mayo Clinic

Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra

Co-Chair: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Speaker: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine

Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Speaker: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.

Speaker: Salomon Manier, MD, PhD – Lille University Hospital

Speaker: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Panelist: Hartmut Goldschmidt, MD (he/him/his) – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)

Panelist: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Panelist: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine

Panelist: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Panelist: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.

Panelist: Salomon Manier, MD, PhD – Lille University Hospital

Co-Chair: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE

Co-Chair: Brian GM Durie – Cedars-SInai Cancer Center, Los Angeles CA 90046

Speaker: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Panelist: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Panelist: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra

Panelist: Ola Landgren, MD, PhD (he/him/his) – University of Miami, Sylvester Comprehensive Cancer Center

Panelist: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Panelist: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Panelist: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra

Speaker: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre

Speaker: Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole

Speaker: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS (he/him/his) – National University Cancer Institute, Singapore

Speaker: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital

Speaker: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany

Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Panelist: Angelo Maiolino – Universidade Federal do Rio de Janeiro

Panelist: Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole

Panelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS (he/him/his) – National University Cancer Institute, Singapore

Panelist: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital

Panelist: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany

Panelist: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Panelist: Susan Bal, MD – University of Alabama at Birmingham

Panelist: Cesar Rodriguez, MD – Icahn School of Medicine at Mount Sinai

Panelist: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Chair: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN

Speaker: Luciano J. Costa, MD, PhD – University of Alabama at Birmingham, Birmingham, AL, USA

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Panelist: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Panelist: Michel Delforge, MD/Phd (he/him/his) – University of Leuven, Leuven, Belgium

Co-Chair: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Chair: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil

Speaker: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute

Speaker: P.Joy Ho, MBBS DPhil FRACP FRCPA – Institute of Haematology, Royal Prince Alfred Hospital

Speaker: Marc S. Raab, MD PhD (he/him/his) – Dept. of Medicine V Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Speaker: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD (she/her/hers) – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia

Speaker: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Panelist: Pankaj Malhotra, MD – Postgraduate Institute of Medical Education and Research, Chandigarh

Panelist: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute

Panelist: P.Joy Ho, MBBS DPhil FRACP FRCPA – Institute of Haematology, Royal Prince Alfred Hospital

Panelist: Marc S. Raab, MD PhD (he/him/his) – Dept. of Medicine V Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Panelist: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD (she/her/hers) – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia

Panelist: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Panelist: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Panelist: Elias K. Mai (he/him/his) – Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Panelist: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Dana-Farber Cancer Institute, Boston, MA, USA

Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Ajai Chari, MD, PhD – University of California, San Francisco

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Speaker: Paola Neri, MD, PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary

Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Panelist: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC

Panelist: Ajai Chari, MD, PhD – University of California, San Francisco

Panelist: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Panelist: Paola Neri, MD, PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary

Panelist: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Co-Chair: Kenneth C. Anderson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Niccolo Bolli, MD, PhD – University of Milan

Panelist: Niccolo Bolli, MD, PhD – University of Milan

Speaker: Jose Angel Martinez-Climent, MD PhD – University of Navarra, Center for Applied Medical Research, Department of Hematology, Clinica Universidad de Navarra Cancer Center, School of Medicine

Panelist: Jose Angel Martinez-Climent, MD PhD – University of Navarra, Center for Applied Medical Research, Department of Hematology, Clinica Universidad de Navarra Cancer Center, School of Medicine

Speaker: Josefine Krüger, MD – Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Panelist: Josefine Krüger, MD – Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Speaker: Sara Taranto, PhD (she/her/hers) – ASST Spedali Civili di Brescia

Panelist: Sara Taranto, PhD (she/her/hers) – ASST Spedali Civili di Brescia

Co-Chair: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration

Speaker: Bindu Kanapuru, MD – Food and Drug Administration

Speaker: Edward Laane, MD, PhD (he/him/his) – Tartu University

Speaker: Michal Zwiewka, MD – Paul-Ehrlich-Institut

Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration

Speaker: Bindu Kanapuru, MD – Food and Drug Administration

Speaker: Edward Laane, MD, PhD (he/him/his) – Tartu University

Speaker: Michal Zwiewka, MD – Paul-Ehrlich-Institut

Co-Chair: Sundar Jagannath, MD, FASCO (he/him/his) – Mount Sinai Medical Center, New York, NY, USA

Co-Chair: Robert Z. Orlowski, PhD, MD (he/him/his) – The University of Texas MD Anderson Cancer Center

Speaker: Jordan M. Schecter, MD (he/him/his) – Janssen R&D, Raritan, NJ, USA

Panelist: Jordan M. Schecter, MD (he/him/his) – Janssen R&D, Raritan, NJ, USA

Speaker: Joanna Opalinska, n/a – GlaxoSmithKline

Panelist: Joanna Opalinska, n/a – GlaxoSmithKline

Speaker: Nathan Martin, PhD (he/him/his) – Bristol Myers Squibb

Panelist: Nathan Martin, PhD (he/him/his) – Bristol Myers Squibb

Speaker: Zandra K. Klippel, MD (she/her/hers) – Sanofi

Panelist: Zandra K. Klippel, MD (she/her/hers) – Sanofi

Speaker: Isabel Perez Cruz, PhD – Pfizer

Panelist: Isabel Perez Cruz, PhD – Pfizer

Chair: Kenneth C. Anderson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Co-Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Speaker: Saad Z. Usmani, MD MBA – Memorial Sloan Kettering Cancer Center

Speaker: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC

Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Speaker: Ashley Rosko, MD (she/her/hers) – The Ohio State University

Speaker: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Panelist: Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)

Panelist: Saad Z. Usmani, MD MBA – Memorial Sloan Kettering Cancer Center

Panelist: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC

Panelist: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Panelist: Ashley Rosko, MD (she/her/hers) – The Ohio State University